Crizotinib vs Placebo for Patients with Tumors Harboring the ALK Fusion Protein (E4512)
Crizotinib vs Placebo for Patients with Tumors Harboring the ALK Fusion Protein (E4512)
Trial Category:
Lung
Phase
III
Contact(s)
Location(s)
Faith Regional Health System, Carson Cancer Center, Norfolk, NE
Great Plains Health, Callahan Cancer Center, North Platte, NE
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Regional West Health Services, Cancer Center, Scottsbluff, NE
Southeast Nebraska Cancer Center, Lincoln, NE
